Pimecrolimus

BreastfeedingPediatric
  • TRADE NAME: Elidel (Valeant)
  • INDICATIONS: Second-line therapy for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis
  • CLASS: Immunomodulator, Macrolactam
  • HALF-LIFE: N/A
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Abatacept, Alcohol, Alefacept, Aprepitant, Azacitidine, Betamethasone, Cabazitaxel, Calcium channel blockers, Cimetidine, Conivaptan, CYP3A4 inhibitors, Darunavir, Delavirdine, Denileukin, Docetaxel, Efavirenz, Erythromycin, Fingolimod, Fluconazole, Gefitinib, Immunosuppressants, Indinavir, Itraconazole, Ketoconazole, Lapatinib, Leflunomide, Lenalidomide, Oxaliplatin, Pazopanib, Pemetrexed, Telithromycin, Temsirolimus, Triamcinolone, Voriconazole

PREGNANCY CATEGORY: C

LONG-TERM SAFETY OF TOPICAL CALCINEURIN INHIBITORS HAS NOT BEEN ESTABLISHED.

See full prescribing information for complete boxed warning.

Our database has 25 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
CARDIOVASCULAR
LOCAL
OCULAR
RESPIRATORY
OTHER


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top